|Bid||9.620 x 0|
|Ask||9.630 x 0|
|Day's Range||9.570 - 9.800|
|52 Week Range||7.080 - 11.163|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||17.35|
|Earnings Date||May 25, 2021 - May 31, 2021|
|Forward Dividend & Yield||0.25 (2.63%)|
|Ex-Dividend Date||May 24, 2021|
|1y Target Est||20.92|
CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC Pharmaceutical" or the "Group") is pleased to announce its interim results for the six months ended 30 June 2020. For the current period, the Group recorded a revenue of RMB12,590 million, an increase of 12.6% year-on-year, and profit attributable to shareholders of RMB2,314 million, an increase of 23.2% year-on-year. Basic earnings per share was RMB30.97 cents. The Board of Directors has declared an interim dividend of HK6 cents per share for 2020 and proposed a bonus issue.
Last week, you might have seen that CSPC Pharmaceutical Group Limited (HKG:1093) released its quarterly result to the...
Dividend paying stocks like CSPC Pharmaceutical Group Limited (HKG:1093) tend to be popular with investors, and for...